Key statistics
On Friday, Marinomed Biotech AG (93Z:BER) closed at 8.68, 108.65% above the 52 week low of 4.16 set on Aug 21, 2024.
52-week range
Open | 8.66 |
---|---|
High | 8.68 |
Low | 8.66 |
Bid | 7.30 |
Offer | 10.05 |
Previous close | 8.68 |
Average volume | 0.00 |
---|---|
Shares outstanding | 1.69m |
Free float | 1.16m |
P/E (TTM) | -- |
Market cap | 15.22m EUR |
EPS (TTM) | -4.46 EUR |
Data delayed at least 15 minutes, as of Oct 18 2024 17:55 BST.
More ▼
Announcements
- EQS-Adhoc: Marinomed Biotech AG begins contract negotiations for the sale of the Carragelose portfolio
- EQS-News: Marinomed Biotech AG publishes remarkable results showing alleviation of allergic eye inflammation in patients treated with Tacrolimus eye drops in peer-reviewed journal
- EQS-PVR: Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution
- EQS-NVR: Marinomed Biotech AG: Release according to Article 135, Section 1 BörseG with the objective of Europe-wide distribution
- EQS-News: Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops
- EQS-DD: Marinomed Biotech AG: Andreas Grassauer, buy
- EQS-DD: Marinomed Biotech AG: Simon Nebel, buy
- EQS-DD: Marinomed Biotech AG: Eva Prieschl-Grassauer, buy
- EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
- EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights
More ▼